Loading match intelligence
Resolves to Yes if a company announces results of a Phase 2 or later clinical trial for a CRISPR-based therapy meeting its primary endpoint, before the close date.
Resolves Yes if Resolves to Yes if a company announces results of a Phase 2 or later clinical trial for a CRISPR-based therapy meeting its primary endpoint, before the close date.
Outcome verified from clinicaltrials.gov.
Trading on material non-public information is prohibited. Markets are for entertainment and informational purposes using free Pulse Credits — no real-money wagering. If you believe a participant has acted on inside information, please report it.
Analyzing this market…